Publications Database

Ashwood P. et al. (2008)

Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Journal of Neuroimmunology

204(1), pp. 149-153

Read Abstract (New Window)

Bent S. et al. (2011)

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder.

Journal of Autism and Developmental Disorders

41(5), pp. 545-554.

Read Abstract (New Window) Read Full (New Window)

Bent S. et al. (2012)

Brief report: Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial.

Journal of Autism and Developmental Disorders

42(6), pp. 1127-1132.

Read Abstract (New Window)

Careaga M. , Van de Water J. , Ashwood P. (2010)

Immune dysfunction in autism: A pathway to treatment.

Neurotherapeutics

7(3), pp. 283-292

Read Abstract (New Window)

Critchfield J. et al. (2011)

The potential role of probiotics in the management of childhood autism spectrum disorders.

Gastroenterology Research and Practice

Read Abstract (New Window) Read Full (New Window)

Gesundheit B. et al. (2015)

Therapeutic properties of mesenchymal stem cells for autism spectrum disorders.

Medical Hypotheses

March, 84(3), pp. 169-177.

Read Abstract (New Window)

Hendren. R. L. et al. (2009)

Mechanistic biomarkers for autism treatment.

Medical Hypotheses

73(6), pp. 950-954.

Read Abstract (New Window)

Lv Y. et al. (2013)

Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism.

Journal of Translational Medicine

11 p. 196

Read Full (New Window)